ArticleCureus2024
Health-Related Quality of Life in Systemic Lupus Erythematosus and Its Relationship With Disease Activity: A Single-Center Cross-Sectional Study From Pakistan.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Quality of Life of Patients with Systemic Lupus Erythematosus in Eastern Saudi Arabia: A Cross-sectional Study.Saudi journal of medicine & medical sciencesArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective This study aims to determine whether disease activity was associated with health-related quality of life (HRQoL) in the Pakistani population with systemic lupus erythematosus (SLE). Methods This cross-sectional study was conducted in the Rheumatology Department of the National Hospital & Medical Centre, Lahore, Pakistan, from April 2021 to June 2022. A sample of 60 patients, both male and female, diagnosed with a case of SLE was collected through the purposive sampling technique. The data were collected through a questionnaire in which the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) was applied to assess age at diagnosis, duration, and activity of SLE. HRQoL was evaluated using the Systemic Lupus Erythematosus-Specific Quality of Life (SLEQOL) questionnaire. A seven-digit Likert scale was developed to apply the Student's t-test. The Pearson test was applied to demographic variables. Results The mean age of the participants was 32.63 ± 11.12 years. The mean SLEDAI score was 5.30 ± 4.96, ranging from 0 to 17. The mean SLEQOL score was 106.2 ± 33.60, with scores ranging from 47 to 199. There was a significant positive correlation between the SLEDAI score and the overall SLEQOL score (r = 0.376, p = 0.003). Significant correlations were also observed between the SLEDAI score and the subdomains of Physical Functioning (r = 0.341, p = 0.008), Activities (r = 0.478, p < 0.001), Symptoms (r = 0.326, p = 0.011), Treatment (r = 0.262, p = 0.044), and Mood (r = 0.297, p = 0.021). No significant correlation was found between the SLEDAI score and the Self-Image subdomain (r = 0.081, p = 0.541). Conclusion High levels of disease, especially fever, pain, and fatigue, cause many obstacles in maintaining life and never help in better understanding the quality of life in terms of physical, psychological, and environmental domains.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.